The company says its ANSWER platform fixes what undid first-generation allogeneic CAR-T, and is pursuing T-cell leukemia and ...

Pritam International used color additive identified as “CI 14720,” also known as Ext. D&C Red No. 10, Acid Red No. 14, Food ...

Major Japanese firms report a generally positive quarter helped by forex effects, leading Takeda and Shionogi to revise ...

Edwards touted PROGRESS data showing SAPIEN 3 TAVR cut heart failure events in moderate AS, while EARLY TAVR economics showed ...

Former Madrigal exec Michael Charlton has filed suit against the firm alleging that he was forced out after raising concerns ...

AbbVie’s victory in a lawsuit over the selection of Botox for Medicare price negotiation is the first by a major manufacturer ...

The pivotal Phase II GRAND CANYON study of the drug, which was part of a June asset purchase from Edgewise worth up to ...

AbbVie VP-global head of immunology clinical development Kori Wallace talked to Scrip about what could be the company’s next ...

Sean Keveney agreed to stay in the job until a successor is found and a transition is completed, but he could be one of ...

The UK’s pilot of voluntary clinical trial diversity plans will expand in early 2027, after commercial sponsors reported ...

Competitive pressure is hitting Bayer’s Nutritionals business, with US multivitamins especially tough, the company told HBW ...

Drug developers could get a faster way to put focused scientific questions to the European Medicines Agency, as the regulator ...